Dr. Michael Tuttle on Dosimetry Versus Empiric Dosing Radioactive Iodine Treatment
October 23rd 2015Michael Tuttle, MD, endocrinologist Memorial Sloan Kettering (MSK), discusses best management approaches to radioactive iodine treatment in patients with radioiodine avid distant metastases from differentiated thyroid cancer.